Eur Rev Med Pharmacol Sci 2023; 27 (5 Suppl): 34-38
DOI: 10.26355/eurrev_202310_34067

Effect of type 1 tympanoplasty on health-related Quality of Life assessed by Chronic Otitis Media Questionnaire 12

M. Demirag Evman, T. Cakil

Department of Otorhinolaryngology, Head and Neck Surgery, University of Health Sciences, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey. melisdemirag@gmail.com


OBJECTIVE: The aim of the study was to evaluate the changes in the quality of life of patients who underwent Type 1 tympanoplasty using the Chronic Otitis Media Questionnaire 12 (COMQ-12).

SUBJECTS AND METHODS: Prospectively collected data of patients aged between 18-65 years, who had undergone type 1 tympanoplasty between January 2018 to January 2019 were included in the study. The Turkish version of COMQ-12 was completed by all of the patients preoperatively as well as 12 months postoperatively. Preoperative and postoperative graft uptake outcomes, hearing assessment results, and scores of COMQ-12 were evaluated. Shapiro-Wilk test, Mann-Whitney U test, and Wilcoxon test were used.

RESULTS: A total of 98 patients were included. Noticeable improvement in the severity of symptoms, negative effect on daily life and work routine, health care, and general well-being was detected by subjective scores of the questionnaire. The COMQ-12 preoperative and postoperative overall average score was 25 and 7, respectively (p<0.001). Graft uptake success was found to be 85%. Hearing assessment evaluation showed a mean change in air conduction values of 8.78 (SD 1.17), and a mean change in air-bone gap values of 7 (SD 0.8), both showing statistical significance (p<0.001).

CONCLUSIONS: According to the COMQ-12 questionnaire data after surgery, symptom severity, lifestyle and work impact, health service impact, and general discomfort were significantly reduced.

Published on: 2023/10/20


Free PDF Download

To cite this article

M. Demirag Evman, T. Cakil
Effect of type 1 tympanoplasty on health-related Quality of Life assessed by Chronic Otitis Media Questionnaire 12

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 5 Suppl
Pages: 34-38
DOI: 10.26355/eurrev_202310_34067